These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 3930653)

  • 61. Effects of rat gamma- and non-gamma-interferons on the expression of Ia antigen, growth, and differentiated functions of FRTL5 cells.
    Misaki T; Tramontano D; Ingbar SH
    Endocrinology; 1988 Dec; 123(6):2849-57. PubMed ID: 2461853
    [TBL] [Abstract][Full Text] [Related]  

  • 62. T cells discriminate between Ia antigens expressed on allogeneic accessory cells and B cells: a potential function for carbohydrate side chains on Ia molecules.
    Cowing C; Chapdelaine JM
    Proc Natl Acad Sci U S A; 1983 Oct; 80(19):6000-4. PubMed ID: 6225126
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Isolation of a functional antigen-Ia complex.
    Srinivasan M; Pierce SK
    Proc Natl Acad Sci U S A; 1990 Feb; 87(3):919-22. PubMed ID: 2153978
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Brain neocortex immunomodulation in rats.
    Barnéoud P; Neveu PJ; Vitiello S; Mormède P; Le Moal M
    Brain Res; 1988 Dec; 474(2):394-8. PubMed ID: 3145098
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Introduction of macromolecules into primary cultured neuronal cells by fusion with erythrocyte ghosts.
    Hikawa N; Horie H; Kawakami T; Okuda K; Takenaka T
    Brain Res; 1989 Feb; 481(1):162-4. PubMed ID: 2495838
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Sialic acid content in serum IgG from patients with myotonic dystrophy compared with healthy controls.
    Sydow O
    Acta Neurol Scand; 1989 Nov; 80(5):476-8. PubMed ID: 2511731
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Hydroxychloroquine Inhibits the Trained Innate Immune Response to Interferons.
    Rother N; Yanginlar C; Lindeboom RGH; Bekkering S; van Leent MMT; Buijsers B; Jonkman I; de Graaf M; Baltissen M; Lamers LA; Riksen NP; Fayad ZA; Mulder WJM; Hilbrands LB; Joosten LAB; Netea MG; Vermeulen M; van der Vlag J; Duivenvoorden R
    Cell Rep Med; 2020 Dec; 1(9):100146. PubMed ID: 33377122
    [TBL] [Abstract][Full Text] [Related]  

  • 68. FDA approved drugs with pharmacotherapeutic potential for SARS-CoV-2 (COVID-19) therapy.
    Drożdżal S; Rosik J; Lechowicz K; Machaj F; Kotfis K; Ghavami S; Łos MJ
    Drug Resist Updat; 2020 Dec; 53():100719. PubMed ID: 32717568
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Hydroxychloroquine and Azithromycin to Treat Patients With COVID-19: Both Friends and Foes?
    Mégarbane B; Scherrmann JM
    J Clin Pharmacol; 2020 Jul; 60(7):808-814. PubMed ID: 32434282
    [No Abstract]   [Full Text] [Related]  

  • 70. Chloroquine inhibits Ca
    Wu YF; Zhao P; Luo X; Xu JC; Xue L; Zhou Q; Xiong M; Shen J; Peng YB; Yu MF; Chen W; Ma L; Liu QH
    Cell Biosci; 2017; 7():28. PubMed ID: 28546857
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Why functional pre-erythrocytic and bloodstage malaria vaccines fail: a meta-analysis of fully protective immunizations and novel immunological model.
    Guilbride DL; Gawlinski P; Guilbride PD
    PLoS One; 2010 May; 5(5):e10685. PubMed ID: 20502667
    [TBL] [Abstract][Full Text] [Related]  

  • 72. New concepts in antimalarial use and mode of action in dermatology.
    Kalia S; Dutz JP
    Dermatol Ther; 2007; 20(4):160-74. PubMed ID: 17970883
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Expression of beta 2-microglobulin-free HLA class I alpha-chains on activated T cells requires internalization of HLA class I heterodimers.
    Pickl WF; Holter W; Stöckl J; Majdic O; Knapp W
    Immunology; 1996 May; 88(1):104-9. PubMed ID: 8707334
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A structural transition in class II major histocompatibility complex proteins at mildly acidic pH.
    Runnels HA; Moore JC; Jensen PE
    J Exp Med; 1996 Jan; 183(1):127-36. PubMed ID: 8551215
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Regulation and targeting of T-cell immune responses by IgE and IgG antibodies.
    Bheekha Escura R; Wasserbauer E; Hammerschmid F; Pearce A; Kidd P; Mudde GC
    Immunology; 1995 Nov; 86(3):343-50. PubMed ID: 8550069
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Relationship between invariant chain expression and major histocompatibility complex class II transport into early and late endocytic compartments.
    Romagnoli P; Layet C; Yewdell J; Bakke O; Germain RN
    J Exp Med; 1993 Mar; 177(3):583-96. PubMed ID: 8436902
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Processing and presentation of tetanus toxin by antigen-presenting cells from patients with chronic granulomatous disease (CGD) to human specific T cell clones are not impaired.
    Barbey C; Tiercy JM; Fairweather N; Niemann H; Seger R; Corradin G
    Clin Exp Immunol; 1994 Feb; 95(2):227-31. PubMed ID: 8306496
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Transport and intracellular distribution of MHC class II molecules and associated invariant chain in normal and antigen-processing mutant cell lines.
    Riberdy JM; Avva RR; Geuze HJ; Cresswell P
    J Cell Biol; 1994 Jun; 125(6):1225-37. PubMed ID: 8207055
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Endosomal aspartic proteinases are required for invariant-chain processing.
    Marić MA; Taylor MD; Blum JS
    Proc Natl Acad Sci U S A; 1994 Mar; 91(6):2171-5. PubMed ID: 8134367
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Separation of subcellular compartments containing distinct functional forms of MHC class II.
    Qiu Y; Xu X; Wandinger-Ness A; Dalke DP; Pierce SK
    J Cell Biol; 1994 May; 125(3):595-605. PubMed ID: 7909813
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.